Evidence map›Paper›PMID 42750193›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Supramolecular Allostery Achieves Tunable Luminescence Aromatic Bridged Phenothiazine Noncovalent Frameworks.

Xinping Lu, Jianchong Chen, Jie Yu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xinping LuYunnan Key Laboratory of Modern Separation Analysis and Substance Transformation, College of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming, People's Republic of China.
Jianchong ChenYunnan Key Laboratory of Modern Separation Analysis and Substance Transformation, College of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming, People's Republic of China.
Jie YuYunnan Key Laboratory of Modern Separation Analysis and Substance Transformation, College of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming, People's Republic of China.ORCID https://orcid.org/0000-0002-0671-3824

Funding

National Natural Science Foundation of China 22201142Xing Dian Talent Support Program FoundationsYunnan Fundamental Research Projects 202601CF070007
6 · The paper itself

Abstract

Here, we report an engineering tunable luminescent supramolecular organic framework (SOF) enabled by multiple allosteric effects, composed of a tetracationic vinylphenylpyridinium-modified aromatic-bridged phenothiazine guest and cucurbit[8]uril in a 1:2 stoichiometric ratio, formed via non-covalent polymerization driven by strong host-guest cooperation. The nanofiber-like guest is activated to form a supramolecular network polymer with negligible luminescence at 815 nm, showing an ultra-large Stokes shift of up to 240 nm. Interestingly, under oxidant driving, the guest allosterically converts to phenothiazine sulfoxide, which makes the weakly luminescent SOF exhibit strong yellow fluorescence, and the emission blueshifts to 610 nm, with the quantum yield increasing 46-fold to 22.2%. Additionally, the dynamic reversibility of macrocyclic bonding endows the SOFs with reversible and dissociative allosteric properties, enabling thermos-reversible regulation of their luminescence and competitive guest-induced quenching performance. Finally, the allosterically controlled luminescent SOF has been successfully applied to information encryption and logic gates, providing a new perspective for developing intelligent supramolecular materials.

Indexed as

cucurbit[8]urilsupramolecular assemblysupramolecular organic frameworktunable luminescence

Identifiers

PMID42750193
PMCPMC13583087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.